These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8241336)

  • 41. Intraperitoneal immunoglobulin (IG) treatment in prophylaxis of bacterial peritonitis in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    Biomater Artif Cells Artif Organs; 1987; 15(1):151-9. PubMed ID: 3329538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Continuous ambulatory peritoneal dialysis-associated peritonitis as a model device-related infection: phenotypic adaptation, the staphylococcal cell envelope and infection.
    Williams P; Swift S; Modun B
    J Hosp Infect; 1995 Jun; 30 Suppl():35-43. PubMed ID: 7560971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Infecting organisms in continuous ambulatory peritoneal dialysis patients on the Y-set.
    Holley JL; Bernardini J; Piraino B
    Am J Kidney Dis; 1994 Apr; 23(4):569-73. PubMed ID: 8154494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heat-killed microorganisms induce PAI-1 expression in human peritoneal mesothelial cells: role of interleukin-1alpha.
    Mandl-Weber S; Haslinger B; Lederer SR; Sitter T
    Am J Kidney Dis; 2001 Apr; 37(4):815-9. PubMed ID: 11273882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intraperitoneal streptokinase in the treatment of recurrent peritonitis.
    Jones BF; Lake N
    Perit Dial Int; 1989; 9(4):352. PubMed ID: 2488396
    [No Abstract]   [Full Text] [Related]  

  • 46. Adult and pediatric peritonitis rates in a home dialysis program: comparison of continuous ambulatory and continuous cycling peritoneal dialysis.
    Howard RL; Millspaugh J; Teitelbaum I
    Am J Kidney Dis; 1990 Nov; 16(5):469-72. PubMed ID: 2239939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
    Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
    Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraperitoneal daptomycin.
    García-López L; Gómez Sayago L; Fernández-Reyes Luis MJ
    Nefrologia; 2011; 31(3):375-6. PubMed ID: 21629351
    [No Abstract]   [Full Text] [Related]  

  • 49. [Reduction in the incidence of peritonitis in continuous ambulatory peritoneal dialysis using a simple microbiological dialysate-check].
    Oliveri M; Záruba K
    Schweiz Rundsch Med Prax; 1982 Oct; 71(43):1696-1700. PubMed ID: 7188555
    [No Abstract]   [Full Text] [Related]  

  • 50. [Our experience with the diagnosis of peritonitis complicating a long-term program of peritoneal dialysis].
    Wańkowicz Z; Panasiuk E; Pietrzak B; Smoszna J; Witman D
    Pol Arch Med Wewn; 1992 Jun; 87(6):386-92. PubMed ID: 1408997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A five-year study of the microbiologic results of exit site infections and peritonitis in continuous ambulatory peritoneal dialysis.
    Piraino B; Bernardini J; Sorkin M
    Am J Kidney Dis; 1987 Oct; 10(4):281-6. PubMed ID: 3661549
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.
    Thodis E; Bhaskaran S; Pasadakis P; Bargman JM; Vas SI; Oreopoulos DG
    Perit Dial Int; 1998; 18(3):261-70. PubMed ID: 9663889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peritonitis associated with continuous ambulatory peritoneal dialysis: the pseudo-surgical abdomen.
    Apostolidis NS; Katirtzoglou AN; Manouras AJ; Moundokalakis TD
    Am Surg; 1993 Jul; 59(7):448-50. PubMed ID: 8323078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients.
    Ariano RE; Franczuk C; Fine A; Harding GK; Zelenitsky SA
    Perit Dial Int; 2002; 22(3):335-8. PubMed ID: 12227390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of an in-vitro model to study the growth characteristics of Staphylococcus epidermidis in continuous ambulatory peritoneal dialysis.
    Brant JA; Hanlon GW; Denyer SP
    J Pharm Pharmacol; 1998 Oct; 50(10):1195-203. PubMed ID: 9821670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Longitudinal study of peritoneal defence mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD).
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Perit Dial Int; 1989; 9(2):115-9. PubMed ID: 2488196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response of chronic renal failure mice to peritoneal Staphylococcus epidermidis challenge: impact of repeated peritoneal instillation of dialysis solution.
    Gallimore B; Gagnon RF; Richards GK
    Am J Kidney Dis; 1989 Sep; 14(3):184-95. PubMed ID: 2773921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of microbiologic characteristics of pathogenic and saprophytic coagulase-negative staphylococci from patients on continuous ambulatory peritoneal dialysis.
    Baddour LM; Smalley DL; Kraus AP; Lamoreaux WJ; Christensen GD
    Diagn Microbiol Infect Dis; 1986 Sep; 5(3):197-205. PubMed ID: 3638993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biomaterial-associated staphylococcal peritoneal infections in a neutropaenic mouse model.
    Rozalska B; Ljungh A
    FEMS Immunol Med Microbiol; 1995 Jul; 11(4):307-19. PubMed ID: 8541809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Staphylococcus epidermidis with intermediate resistance to vancomycin: elusive phenotype or laboratory artifact?
    Dunne WM; Qureshi H; Pervez H; Nafziger DA
    Clin Infect Dis; 2001 Jul; 33(1):135-7. PubMed ID: 11389509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.